117 related articles for article (PubMed ID: 11616314)
1. Marion Merrell Dow - historical perspective of a "merging" company.
Irwin TR
Pharm Hist (Lond); 1994 Jun; 24(2):7-12. PubMed ID: 11616314
[No Abstract] [Full Text] [Related]
2. Congressional action to amend Federal Rule of Evidence 702: a mischievous attempt to codify Daubert v. Merrell Dow Pharmaceuticals, Inc.
Farrell NS
J Contemp Health Law Policy; 1997; 13(2):523-51. PubMed ID: 9212529
[No Abstract] [Full Text] [Related]
3. Charles Fletcher, The Centaur Company, and Proprietary Medicine Revenue Stamps.
Steensma DP; Kyle RA
Mayo Clin Proc; 2017 Sep; 92(9):e127-e128. PubMed ID: 28870369
[No Abstract] [Full Text] [Related]
4. Historical images of the drug market- LII.
Helfand WH
Pharm Hist; 1996; 38(4):180-2. PubMed ID: 11618762
[No Abstract] [Full Text] [Related]
5. Eighth annual Marion Merrell Dow Hypertension Research Clinical Fellowship Award. 1991.
Hypertension; 1992 Jun; 19(6 Pt 2):820. PubMed ID: 1592487
[No Abstract] [Full Text] [Related]
6. The Rise and Fall of the Liverpool Apothecaries Company 1836 to 1904.
Anderson SA
Pharm Hist (Lond); 2016 Mar; 46(1):17-22. PubMed ID: 29998721
[No Abstract] [Full Text] [Related]
7. The evolution of the American pharmaceutical industry.
Swann JP
Pharm Hist; 1995; 37(2):76-86. PubMed ID: 11639647
[No Abstract] [Full Text] [Related]
8. The pharmaceutical industry, 1852-1902.
Worthen DB
J Am Pharm Assoc (Wash); 2000; 40(5):589-91. PubMed ID: 11029839
[No Abstract] [Full Text] [Related]
9. Tenth Annual Marion Merrell Dow Hypertension Research Clinical Fellowship Award. 1993.
Hypertension; 1994 Jun; 23(6 Pt 2):1151. PubMed ID: 8206607
[No Abstract] [Full Text] [Related]
10. The Anglo-American Pharmaceutical Company Limited.
Cox N
Pharm Hist (Lond); 2015 Jun; 45(2):44-8. PubMed ID: 26521621
[No Abstract] [Full Text] [Related]
11. ["100 years' service to man." Milestones of the Hoechst Pharmaceutical Company].
Gericke D
Fortschr Med; 1984 May; 102(20):75-7. PubMed ID: 6376304
[No Abstract] [Full Text] [Related]
12. [Drug industry in France: some historical points].
Sigvard J
Bull Acad Natl Med; 1982 Jun; 166(6):829-34. PubMed ID: 6756598
[No Abstract] [Full Text] [Related]
13. The pharmaceutical industry: the true perspective.
Holland K
Pharm Hist (Lond); 1992 Mar; 22(1):3-11. PubMed ID: 11612796
[No Abstract] [Full Text] [Related]
14. [The highest requirement for work: making health pay off. Retrospective of a long-standing company tradition of the Boehringer Mannheim Company].
Höpfinger E
Fortschr Med; 1984 Apr; 102(16):91-2. PubMed ID: 6724482
[No Abstract] [Full Text] [Related]
15. Squibb ER: Know your suppliers..."the priceless ingredient".
J Am Pharm Assoc; 1969 Nov; 9(11):576-9. PubMed ID: 4900094
[No Abstract] [Full Text] [Related]
16. Foreign influences, national styles, and the creation of a modern pharmaceutical industry in Britain and France.
Quirke V
Pharm Hist; 2010; 52(3-4):134-47. PubMed ID: 21688739
[No Abstract] [Full Text] [Related]
17. Henry Wellcome (1853-1936) and his institute.
James DG
J Med Biogr; 2009 Aug; 17(3):178. PubMed ID: 19723976
[No Abstract] [Full Text] [Related]
18. Ten years on--the European perspective. Biotech company founders talk about what made their companies tick.
Collingham DP
Biotechnology (N Y); 1993 Mar; 11(3):S44-6. PubMed ID: 7763435
[No Abstract] [Full Text] [Related]
19. Hubert Harrington Warner, the patent medicine "king".
Miller G
Pharm Hist Aust; 1998 Jan; (4):3-6. PubMed ID: 11619848
[No Abstract] [Full Text] [Related]
20. Historical aspects of pharmacologic research at Bayer. 1890-1990.
Schadewaldt H
Stroke; 1990 Dec; 21(12 Suppl):IV5-8. PubMed ID: 2260149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
